People: Omnicell Inc (OMCL.OQ)

OMCL.OQ on NASDAQ Stock Exchange Global Select Market

32.66USD
19 Dec 2014
Price Change (% chg)

$0.27 (+0.83%)
Prev Close
$32.39
Open
$32.35
Day's High
$32.78
Day's Low
$32.16
Volume
163,622
Avg. Vol
71,087
52-wk High
$34.00
52-wk Low
$24.96

Search Stocks

Summary

Name Age Since Current Position

Randall Lipps

56 2002 Chairman of the Board, President, Chief Executive Officer

Robin Seim

54 2012 Chief Financial Officer, Executive Vice President - Finance, Administration and Manufacturing

Daniel Johnston

50 2012 Executive Vice President, General Counsel

Marga Ortigas-Wedekind

52 2012 Executive Vice President - Global Marketing and Product Development

J. Christopher Drew

48 2012 Executive Vice President - Field Operations

Nhat Ngo

41 2012 Executive Vice President - Strategy and Business Development

Jorge Taborga

54 2013 Executive Vice President - Engineering

James Judson

59 2014 Lead Independent Director

Bruce Smith

2014 Director

Joanne Bauer

58 2014 Independent Director

Randy Lindholm

59 2003 Independent Director

Vance Moore

53 2012 Independent Director

Mark Parrish

58 2013 Independent Director

Gary Petersmeyer

67 2007 Independent Director

Sara White

68 2003 Independent Director

Michelle Smith

Executive Assistant, Investor Relations Contact

Biographies

Name Description

Randall Lipps

Mr. Randall A. Lipps is Chairman of the Board, President, Chief Executive Officer of Omnicell Inc. He has served as Chairman of the Board and a director of Omnicell since founding Omnicell in September 1992 and as its President and Chief Executive Officer since October 2002. From 1989 to 1992, Mr. Lipps served as the Senior Vice President of ST. Holdings, Inc., a travel and marketing company. From 1987 to 1989, he served as Assistant Vice President of Sales and Operations for a subsidiary of AMR, the parent company of American Airlines, Inc. Mr. Lipps received both a B.S. in economics and a B.B.A. from Southern Methodist University.

Robin Seim

Mr. Robin G. Seim is Chief Financial Officer, Executive Vice President - Finance, Administration and Manufacturing of Omnicell, Inc. He joined Omnicell in February 2006 as Vice President and was named Chief Financial Officer in March 2006. In January 2009, Mr. Seim was named Chief Financial Officer and Vice President Finance, Administration and Manufacturing. In March 2012, Mr. Seim was named Executive Vice President Finance, Administration and Manufacturing and Chief Financial Officer. Prior to joining Omnicell, Mr. Seim served as Chief Financial Officer of several technology companies, including Villa Montage Systems, Inc. from 1999 to 2001, Candera, Inc. from 2001 to 2004 and Mirra, Inc., in 2005. Prior to 1999, Mr. Seim held a number of management positions with Nortel Networks, Bay Networks, and IBM. Mr. Seim received a B.S. in accounting from California State University, Sacramento.

Daniel Johnston

Mr. Dan S. Johnston is Executive Vice President, General Counsel of Omnicell, Inc. Dan joined Omnicell in November 2003 as Vice President and General Counsel. In March 2012, Mr. Johnston was named Executive Vice President and General Counsel. From April 1999 to November 2003, Mr. Johnston was Vice President and General Counsel at Be, Inc., a software company. From September 1994 to March 1999, Mr. Johnston was an attorney with the law firm Cooley LLP. Mr. Johnston received a B.S. in computer information systems from Humboldt State University and a J.D. from the Santa Clara University School of Law.

Marga Ortigas-Wedekind

Ms. Marga Ortigas-Wedekind is Executive Vice President - Global Marketing and Product Development of Omnicell, Inc. Marga joined Omnicell in January of 2009 as Vice President, Marketing. In May 2009, she was named Vice President, Global Marketing and Product Development. In March 2012, Ms. Ortigas-Wedekind was named Executive Vice President, Global Marketing and Product Development. From February 2002 to October 2008, Ms. Ortigas-Wedekind was the Senior Vice President Marketing, Development, and Clinical Affairs of Xoft, Inc., a medical device company. Ms. Ortigas-Wedekind's earlier career includes several senior marketing roles, including Guidant Corporation's Vascular Intervention Division from January 1990 to February 2000, covering international and worldwide sales and marketing, and culminating in the role of Director, Market Development. She received a B.A. in political economics from Wellesley College and an M.B.A. from the Stanford Graduate School of Business.

J. Christopher Drew

Mr. J. Christopher Drew is Executive Vice President - Field Operations of Omnicell, Inc. Mr. Drew joined Omnicell in April 1994 and was named Senior Vice President, Operations in January 2005. In January 2009, Mr. Drew was named Senior Vice President, Field Operations. In March 2012, Mr. Drew was named Executive Vice President, Field Operations. From April 1994 to January 2005, Mr. Drew served in various management positions with Omnicell, including Vice President of Branded Solutions and Director of Corporate Development. Mr. Drew received a B.A. in economics from Amherst College and an M.B.A. from the Stanford Graduate School of Business.

Nhat Ngo

Mr. Nhat H. Ngo is Executive Vice President - Strategy and Business Development of Omnicell, Inc. Nhat joined Omnicell in November 2008 as Vice President of Strategy and Business Development. In March 2012, Mr. Ngo was named Executive Vice President, Strategy and Business Development. From January 2007 to October 2008, Mr. Ngo served as Vice President of Business Development and Licensing for a business unit of Covidien, a global healthcare products company. From June 1999 to April 2006, Mr. Ngo worked at BriteSmile, Inc., a direct-to-consumer aesthetic technology company and served in a variety of senior leadership positions in marketing, sales, operations, strategic planning and corporate development. From September 1997 to June 1999, Mr. Ngo practiced corporate law at Shaw Pittman, LLP. Mr. Ngo received a B.S. in commerce, with a concentration in finance, from the University of Virginia McIntire School of Commerce and a J.D. from the University of Virginia School of Law.

Jorge Taborga

Mr. Jorge R. Taborga is Executive Vice President - Engineering of Omnicell Inc. Jorge joined Omnicell in July 2007 as Vice President and Chief Information Officer. In February of 2013, he was named Executive Vice President, Engineering. From January 2009 to February 2013, Mr. Taborga was Vice President of Manufacturing, Quality and Information Technology. Prior to joining Omnicell, Mr. Taborga held a number of executive positions with Bay Networks and Quantum, and ran his own management consulting company. He also held executive roles in two cloud computing companies, fusionOne and Terrasping. Mr. Taborga's earlier career includes senior roles in product development with ROLM Systems and Thomas-Conrad. Mr. Taborga received B.S. and M.S. degrees in Computer Science from Texas A&M University. He is currently pursuing a Ph.D. in Organizational Systems at Saybrook University.

James Judson

Mr. James T. Judson is Lead Independent Director of Omnicell Inc. He has served as a director of Omnicell since April 2006. Since March 2006, Mr. Judson has served as a financial executive advisor to small and mid-sized companies. Mr. Judson served as interim Chief Financial Officer of Extreme Networks, Inc., a technology company from March 2011 to July 2012. From April 2005 to March 2006, Mr. Judson was Omnicell's Interim Chief Financial Officer. From February 2005 to April 2005, Mr. Judson was Omnicell's Vice President of Finance. From 1998 until his retirement in January 2002, Mr. Judson served as Vice President of Finance and Planning for the Worldwide Operations group of Sun Microsystems, Inc., a computer systems company. Mr. Judson received a B.S. in industrial management from Purdue University and an M.B.A. from Indiana University.

Bruce Smith

Mr. Bruce D. Smith is Director of the Company. With more than 25 years of health IT experience, Mr. Smith brings a unique understanding of the technology challenges facing today’s hospitals and health systems. With a staff of 500 and an operating budget of $130 million, Mr. Smith’s division supports a network of financial and clinical applications that have been integrated to share information throughout the Advocate system. Previously, Mr. Smith was Vice President and Chief Information Officer for Lutheran General HealthSystem. He began his career with Sears, where he became involved in the development of computer programs in the merchandising division. Mr. Smith is a member of Health Information Management Systems Society (HIMSS), the HIMSS Chicago CIO Roundtable and the Scottsdale Institute, a healthcare executive resource for information management. He received his Bachelor of Business degree from Western Illinois University and his M.B.A. from Loyola University Chicago.

Joanne Bauer

Ms. Joanne B. Bauer has been appointed as a Independent Director of Omnicell, Inc., effective January 1, 2014. Ms. Bauer leads multispecialty businesses across the pain management, respiratory, digestive health and infection prevention sectors. She joined Kimberly-Clark in 1981 and has held various marketing and management positions within its adult care and health care businesses. She was elected president of Kimberly-Clark's global health care business in 2006, where she is responsible for a variety of surgical and infection prevention products and medical devices. Ms. Bauer served on the board of directors for Medivance, Inc., a startup medical device company that was sold to BARD in October of 2011. She currently serves on the executive committee of the board of directors for MedShare, an Atlanta based non-profit organization, and the board of directors of AdvaMed-the Advanced Medical Technology Association.

Randy Lindholm

Mr. Randy D. Lindholm serves as Independent Director of Omnicell Inc. He has served as a director of Omnicell since May 2003. Since April 2002, Mr. Lindholm has served as a consultant to medical device companies. From June 1999 to April 2002, Mr. Lindholm was Chairman, President and Chief Executive Officer of VidaMed, Inc., a medical device company, and from August 1998 to June 1999, served as its Executive Vice President, Sales and Marketing. From 1993 to 1998, Mr. Lindholm held senior field operations positions at Nellcor Puritan Bennett, a provider of solutions to diagnose, monitor and treat respiratory-impaired patients. Mr. Lindholm spent the previous 16 years at GE Medical Systems, a medical device company. Mr. Lindholm received a B.S. in electrical engineering from Michigan Tech University. Mr. Lindholm is also a director of several privately held companies.

Vance Moore

Mr. Vance B. Moore is an Independent Director of Omnicell Inc,. Mr. Moore has served as Senior Vice President, Operations of Mercy Health, a national healthcare system. From July 2006 to April 2011, Mr. Moore served as the President and Chief Executive Officer of Resource Optimization and Innovation (ROi), the supply chain operating division of Mercy Health. From August 1998 to March 2007, Mr. Moore served in various capacities at ROi, including Chief Operating Officer. From March 1999 to March 2002, Mr. Moore served as the Vice President, Sales and Marketing of the Healthcare Services Division of UPS Logistics Group, a global supply chain management services company. Mr. Moore received a B.S. in industrial management from the .

Mark Parrish

Mr. Mark W. Parrish is Independent Director of Omnicell Inc,. Since 2008, Mr. Parrish has served as Chairman and Chief Executive Officer of TridentUSA Health Services, a provider of mobile X-ray and laboratory services to the long-term care industry. Earlier, commencing in 2001, he held management roles of increasing significance with Cardinal Health Inc. and its affiliates, including Chief Executive Officer of Healthcare Supply Chain Services for Cardinal Health from 2006 to 2007. Mr. Parrish also serves as a director of Mylan Inc., a global pharmaceutical company; President of the International Federation of Pharmaceutical Wholesalers, an association of pharmaceutical wholesalers and pharmaceutical supply chain service companies; and senior adviser to Frazier Healthcare Ventures, a health care oriented growth equity firm. Mr. Parrish received a B.A. from the University of California, Berkeley.

Gary Petersmeyer

Mr. Gary S. Petersmeyer serves as the Independent Director of Omnicell Inc. He has served as a director of Omnicell since January 2007. From December 2004 to 2010, Mr. Petersmeyer served as the Chairman and Chief Executive Officer of Aesthetic Sciences Corporation, a research-based medical device company focusing on elective surgery applications. From November 2001 to November 2004, Mr. Petersmeyer provided consulting and executive coaching services to senior executives in high growth and research-based organizations. From 2000 to 2001, Mr. Petersmeyer was President and a Director of Pherin Pharmaceuticals, Inc., a pharmaceutical development and discovery company. From 1995 to 2000, he was President, Chief Executive Officer and a Director of Collagen Corporation, a medical technology company focused on worldwide collagen research. Mr. Petersmeyer received a B.A. in political science from Stanford University, an M.A.T. in teaching from the Harvard Graduate School of Education and an M.B.A. from Harvard University. Mr. Petersmeyer is also a director of The Cooper Companies, Inc., a global medical device company.

Sara White

Ms. Sara J. White serves as the Independent Director of Omnicell Inc. She has served as a director of Omnicell since April 2003. Since April 2004, Ms. White has served as a pharmacy leadership coach. From 1992 to March 2004, Ms. White was a clinical professor at the School of Pharmacy at the University of California, San Francisco. From 1995 to March 2004, Ms. White was an adjunct professor at the University of the Pacific, School of Pharmacy. From 1992 to 2003, Ms. White was the Director of Pharmacy at Stanford Hospital and Clinics. Ms. White received a B.S. in pharmacy from Oregon State University and an M.S. and Residency in hospital pharmacy management from Ohio State University.

Michelle Smith

Basic Compensation

Options Compensation

Name Options Value

Randall Lipps

1,376,434 6,630,068

Robin Seim

38,905 278,326

Daniel Johnston

50,000 101,473

Marga Ortigas-Wedekind

10,545 142,172

J. Christopher Drew

585,843 3,047,864

Nhat Ngo

95,545 919,587

Jorge Taborga

0 0

James Judson

200,000 239,999

Bruce Smith

0 0

Joanne Bauer

0 0

Randy Lindholm

0 0

Vance Moore

0 0

Mark Parrish

0 0

Gary Petersmeyer

0 0

Sara White

0 0

Michelle Smith

0 0
Search Stocks